Skip to content

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

GoodRx Holdings, Inc.

CIK 1809519 GDRX·Services · All EDGAR filings ↗

Progression

2026-03-18 Auditor change 8-K
2026-03-27 Finance chief departure 8-K +9d

Finance chief departure Filing comparison 2026-03-27

GoodRx Holdings, Inc.'s Chief Accounting Officer departed and a successor was named

Evidence

Interim only: No
Item code: 5.02
Item title: Departure of Directors or Certain Officers
Role: Chief Accounting Officer
Severity: normal
Source: SEC 8-K item code
Successor named: Yes
Why: The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗

Auditor change SEC item code 2026-03-18

GoodRx Holdings, Inc. reported a change in its independent accounting firm

The company dismissed the auditor. PwC → not stated No disagreements disclosed.

Evidence

Direction: dismissed
Direction label: The company dismissed the auditor
Disagreements disclosed: No
Item code: 4.01
Item title: Changes in Registrant's Certifying Accountant
Predecessor auditor: PwC
Predecessor tier: big_four
Severity: normal
Source: SEC 8-K item code
Why: The company's independent registered accounting firm changed.

Source filing ↗